<div id="readability-page-1"><p>Swedbank AB increased its position in shares of  Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 112.4% in the first quarter, according to the company in its most recent disclosure with the SEC. The institutional investor  owned 392,349 shares of the medical equipment provider's stock after buying an additional 207,660 shares during the quarter. Swedbank AB owned 0.11% of Intuitive Surgical worth $194,319,000 as of its most recent SEC filing.</p><ul><li>3 Robotics Stocks at the Heart of the Robotics Revolution</li></ul><p>A number of other hedge funds have also modified their holdings of the company. Chilton Capital Management LLC boosted its position in  Intuitive Surgical by 614.3% during the first quarter. Chilton Capital Management LLC now owns 50 shares of the medical equipment provider's stock valued at $25,000 after purchasing an additional 43 shares during the last quarter.  Global Financial Private Client LLC boosted its position in  Intuitive Surgical by 253.3% during the first quarter. Global Financial Private Client LLC now owns 53 shares of the medical equipment provider's stock valued at $26,000 after purchasing an additional 38 shares during the last quarter.  Elite Financial Inc. acquired a new position in  Intuitive Surgical during the first quarter valued at approximately $26,000.  LFA Lugano Financial Advisors SA acquired a new position in  Intuitive Surgical during the first quarter valued at approximately $30,000.  Finally, TD Capital Management LLC boosted its position in  Intuitive Surgical by 300.0% during the first quarter. TD Capital Management LLC now owns 60 shares of the medical equipment provider's stock valued at $30,000 after purchasing an additional 45 shares during the last quarter. 83.64% of the stock is currently owned by institutional investors. </p><div><p><span></span><span>Get <strong>Intuitive Surgical</strong> alerts:</span></p></div><h2>Analyst Ratings Changes</h2><p>ISRG has been the subject of several recent research reports. Zacks Research cut Intuitive Surgical from a &#34;strong-buy&#34; rating to a &#34;hold&#34; rating in a research report on Wednesday, August 20th. Truist Financial increased their price target on Intuitive Surgical from $590.00 to $600.00 and gave the company a &#34;buy&#34; rating in a research report on Wednesday, July 23rd. Erste Group Bank  reissued a &#34;hold&#34; rating on shares of Intuitive Surgical in a research report on Wednesday, July 23rd. Citigroup  reissued a &#34;buy&#34; rating and set a $650.00 price target (up from $590.00) on shares of Intuitive Surgical in a research report on Thursday, May 22nd. Finally, Wall Street Zen raised Intuitive Surgical from a &#34;hold&#34; rating to a &#34;buy&#34; rating in a research report on Saturday, July 26th. Thirteen equities research analysts have rated the stock with a Buy rating, six have given a Hold rating and one  has issued  a Sell rating to the company's stock. Based on data from MarketBeat.com, the stock  has an average rating of &#34;Moderate Buy&#34; and an average target price of $595.95.</p><ul><li> Intuitive Surgical Crushes Q2 Expectations, So Why No Rally?</li></ul><p><b>Read Our Latest Stock Analysis on ISRG</b></p><h2>Intuitive Surgical Stock Up 1.3%</h2><p>ISRG opened at $455.85 on Friday. Intuitive Surgical, Inc. has a 12-month low of $425.00 and a 12-month high of $616.00. The stock has a market cap of $163.41 billion, a price-to-earnings ratio of 63.58, a PEG ratio of 4.72 and a beta of 1.61. The business has a 50 day moving average of $487.55 and a 200-day moving average of $509.57. </p><ul><li>5 Robotics Stocks to Buy for the Future of Automation</li></ul><p>Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last released its quarterly earnings data on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.93 by $0.26. Intuitive Surgical had a return on equity of 14.56% and a net margin of 28.51%.The company had revenue of $2.44 billion during the quarter, compared to analysts' expectations of $2.35 billion. During the same period last year, the firm posted $1.78 earnings per share. The business's revenue was up 21.4% on a year-over-year basis.  As a group, analysts expect that  Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year. </p><h2>Insider Transactions at Intuitive Surgical</h2><p>In other news, EVP Myriam Curet sold 4,500 shares of the stock in a transaction that occurred on Friday, July 25th. The stock was sold at an average price of $492.48, for a total transaction of $2,216,160.00. Following the transaction, the executive vice president owned 353 shares in the company, valued at approximately $173,845.44. This trade represents a 92.73% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities &amp; Exchange Commission, which is accessible through this link. Also, insider Gary S. Guthart sold 29,360 shares of the stock in a transaction that occurred on Friday, August 29th. The stock was sold at an average price of $472.49, for a total value of $13,872,306.40. Following the transaction, the insider owned 19,827 shares in the company, valued at approximately $9,368,059.23. This trade represents a 59.69% decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 45,224 shares of company stock worth $21,716,492. Company insiders own  0.70% of the company's stock. </p><h2>Intuitive Surgical Profile</h2> (Free Report)<p>Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.</p><h2>Read More</h2><ul><li>Five stocks we like better than Intuitive Surgical</li><li>Best Aerospace Stocks Investing </li><li>High-Flyers Near Resistance: 3 Stocks to Watch for a Dip</li><li>Consumer Discretionary Stocks Explained</li><li>Seagate Technology Leads S&amp;P 500: What’s Behind Its 120% Gain?</li><li>Profitably Trade Stocks at 52-Week Highs</li><li>Vanguard’s VUG ETF: The Ultimate Growth ETF for Your Portfolio</li></ul><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9SVNSRw?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="650" height="350" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9SVNSRw"/></p><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><h2>Should You Invest $1,000 in Intuitive Surgical Right Now?</h2><p>Before you consider Intuitive Surgical, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Intuitive Surgical wasn't on the list.</p><p>While Intuitive Surgical currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

ISRG

<p>Swedbank AB has increased its stake in Intuitive Surgical, Inc. (NASDAQ: ISRG) by 112.4% in Q1, acquiring an additional 207,660 shares, bringing its total to 392,349 shares valued at $194.3 million. Other hedge funds have also increased their holdings. Analysts have mixed ratings on the stock, with a consensus rating of "Moderate Buy" and an average target price of $595.95. Intuitive Surgical reported strong Q2 earnings, beating estimates with $2.19 EPS and $2.44 billion in revenue, a 21.4% year-over-year increase.</p>

Swedbank AB Purchases 207,660 Shares of Intuitive Surgical, Inc. $ISRG